Retrosense Therapeutics LLC Ann Arbor, MI - 48104

Retrosense Therapeutics LLC is categorized under Diagnostic Substances in Ann Arbor, MI and active since 2009.

Retrosense Therapeutics LLC was established in 2009, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Diagnostic Substances business, which does work in the B2B market, and is classified as a Diagnostic Substances, under code number 325412 by the NAICS.

If you are seeking more information, feel free to contact Sean Ainsworth at the company’s single location by writing to 330 East Liberty St Lvla, Ann Arbor, Michigan MI 48104 or by phoning (734) 369-9333. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Retrosense Therapeutics LLC
Contact Person: Sean Ainsworth
Address: 330 East Liberty St Lvla, Ann Arbor, Michigan 48104
Phone Number: (734) 369-9333
Website Address: retro-sense.com
Annual Revenue (USD): $100.000 to $499.999
Founded: 2009
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Diagnostic Substances
SIC Code: 2835
NAICS Code: 325412
Share This Business:

Retrosense Therapeutics LLC was started in 2009 to provide professional Diagnostic Substances under the SIC code 2835 and NAICS code 325412. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.

Feel free to contact Sean Ainsworth for inquiries that concern Retrosense Therapeutics LLC by calling the company number (734) 369-9333, as your correspondence is most welcome. Additionally, the physical location of the single location of Retrosense Therapeutics LLC can be found at the coordinates 42.279278,-83.74434 as well as the street address 330 East Liberty St Lvla in Ann Arbor, Michigan 48104.

For its online presence, you may visit Retrosense Therapeutics LLC’s website at retro-sense.com and engage with its social media outlets through on Twitter and on Facebook.